---
title: "Alphatec Holdings, Inc. (ATEC.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ATEC.US.md"
symbol: "ATEC.US"
name: "Alphatec Holdings, Inc."
industry: "Health Care Equipment"
datetime: "2026-05-20T10:12:22.715Z"
locales:
  - [en](https://longbridge.com/en/quote/ATEC.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ATEC.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ATEC.US.md)
---

# Alphatec Holdings, Inc. (ATEC.US)

## Company Overview

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | US Market |
| Website | [www.atecspine.com](https://www.atecspine.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:15.000Z

**Overall: C (0.41)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 61 / 183 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 22.55% |  |
| Net Profit YoY | 24.27% |  |
| P/B Ratio | -236.42 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 1264148087.10 |  |
| Revenue | 787083000.00 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 274.65% | A |
| Profit Margin | -15.93% | D |
| Gross Margin | 71.04% | A |
| Revenue YoY | 22.55% | A |
| Net Profit YoY | 24.27% | B |
| Total Assets YoY | 1.78% | C |
| Net Assets YoY | 129.29% | A |
| Cash Flow Margin | -41.13% | E |
| OCF YoY | 22.55% | A |
| Turnover | 0.99 | A |
| Gearing Ratio | 97.72% | E |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Alphatec Holdings, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "22.55%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "24.27%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "-236.42",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "1264148087.10",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "787083000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "274.65%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "-15.93%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "71.04%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "22.55%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "24.27%",
          "rating": "B"
        },
        {
          "name": "Total Assets YoY",
          "value": "1.78%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "129.29%",
          "rating": "A"
        },
        {
          "name": "Cash Flow Margin",
          "value": "-41.13%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "22.55%",
          "rating": "A"
        },
        {
          "name": "Turnover",
          "value": "0.99",
          "rating": "A"
        },
        {
          "name": "Gearing Ratio",
          "value": "97.72%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -10.08 | 145/183 | - | - | - |
| PB | -236.42 | 165/183 | 255.63 | 149.58 | 97.55 |
| PS (TTM) | 1.61 | 41/183 | 3.62 | 2.95 | 2.44 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Delcath (DCTH.US) | C | A | B | A | A | A |
| 02 | Electromed (ELMD.US) | A | B | A | A | B | A |
| 03 | Intuitive Surgical (ISRG.US) | A | B | C | A | B | B |
| 04 | Stryker (SYK.US) | A | C | C | C | B | B |
| 05 | Boston Scientific (BSX.US) | A | B | C | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-12T04:00:00.000Z

Total Analysts: **12**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 8 | 67% |
| Overweight | 4 | 33% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 8.22 |
| Highest Target | 28.00 |
| Lowest Target | 20.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/ATEC.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/ATEC.US/norm.md)
- [Related News](https://longbridge.com/en/quote/ATEC.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/ATEC.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**